Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Cash from Investing Activities (2024 - 2025)

Indivior Pharmaceuticals (INDV) has 2 years of Cash from Investing Activities data on record, last reported at -$24.0 million in Q4 2025.

  • For Q4 2025, Cash from Investing Activities changed N/A year-over-year to -$24.0 million; the TTM value through Dec 2025 reached -$66.0 million, changed N/A, while the annual FY2025 figure was -$66.0 million, N/A changed from the prior year.
  • Cash from Investing Activities reached -$24.0 million in Q4 2025 per INDV's latest filing, down from -$20.0 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $35.0 million in Q3 2024 and bottomed at -$24.0 million in Q4 2025.